IL116433A - INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17β-OESTRADIOL PRECURSORS - Google Patents
INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17β-OESTRADIOL PRECURSORSInfo
- Publication number
- IL116433A IL116433A IL11643395A IL11643395A IL116433A IL 116433 A IL116433 A IL 116433A IL 11643395 A IL11643395 A IL 11643395A IL 11643395 A IL11643395 A IL 11643395A IL 116433 A IL116433 A IL 116433A
- Authority
- IL
- Israel
- Prior art keywords
- oestradiol
- precursor
- moiety
- group
- drug delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Reproductive Health (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IES940976 | 1994-12-19 | ||
IES950247 | 1995-04-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL116433A0 IL116433A0 (en) | 1996-03-31 |
IL116433A true IL116433A (en) | 2002-02-10 |
Family
ID=26319777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11643395A IL116433A (en) | 1994-12-19 | 1995-12-18 | INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17β-OESTRADIOL PRECURSORS |
Country Status (19)
Country | Link |
---|---|
US (1) | US5855906A (xx) |
EP (1) | EP0799025B1 (xx) |
JP (1) | JPH10510825A (xx) |
CN (1) | CN1138526C (xx) |
AR (1) | AR002010A1 (xx) |
AT (1) | ATE178204T1 (xx) |
AU (1) | AU692659B2 (xx) |
CA (1) | CA2207622C (xx) |
DE (1) | DE69508791T2 (xx) |
DK (1) | DK0799025T3 (xx) |
ES (1) | ES2133841T3 (xx) |
FI (1) | FI119414B (xx) |
GR (1) | GR3030614T3 (xx) |
IL (1) | IL116433A (xx) |
NO (1) | NO316707B1 (xx) |
NZ (1) | NZ298490A (xx) |
PE (1) | PE62796A1 (xx) |
TR (1) | TR199501599A2 (xx) |
WO (1) | WO1996019196A1 (xx) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6407082B1 (en) * | 1996-09-13 | 2002-06-18 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of a vitamin D compound |
US6765002B2 (en) | 2000-03-21 | 2004-07-20 | Gustavo Rodriguez | Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium |
US6028064A (en) | 1996-09-13 | 2000-02-22 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of progestin products |
US6034074A (en) | 1996-09-13 | 2000-03-07 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of a Vitamin D compound |
US6511970B1 (en) | 1996-09-13 | 2003-01-28 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium |
ES2187024T3 (es) * | 1997-05-07 | 2003-05-16 | Galen Chemicals Ltd | Dispositivo intravaginales de liberacion de farmacos para la adimistracion testosterona y de precursores de testosterona. |
US6039968A (en) * | 1997-06-24 | 2000-03-21 | Hoechst Marion Roussel | Intravaginal drug delivery device |
US20050113351A1 (en) * | 2000-03-21 | 2005-05-26 | Rodriguez Gustavo C. | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium |
US20010044431A1 (en) * | 2000-03-21 | 2001-11-22 | Rodriguez Gustavo C. | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium |
US20040176336A1 (en) * | 2000-03-21 | 2004-09-09 | Rodriguez Gustavo C. | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium |
US6811549B2 (en) | 2001-02-16 | 2004-11-02 | William H. Fleming | Administration of therapeutic or diagnostic agents using interlabial pad |
US6962908B2 (en) * | 2001-12-21 | 2005-11-08 | Warner Chilcott Company Inc. | Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
WO2003080019A1 (en) * | 2002-03-27 | 2003-10-02 | Galen (Chemicals) Limited | Intravaginal reservoir drug delivery devices |
GB0222522D0 (en) | 2002-09-27 | 2002-11-06 | Controlled Therapeutics Sct | Water-swellable polymers |
AU2004233997C1 (en) * | 2003-04-29 | 2014-01-30 | Massachusetts Institiute Of Technology | Methods and devices for the sustained release of multiple drugs |
GB0417401D0 (en) | 2004-08-05 | 2004-09-08 | Controlled Therapeutics Sct | Stabilised prostaglandin composition |
CA2596933A1 (en) * | 2005-02-03 | 2006-08-10 | Duramed Pharmaceuticals, Inc. | Devices for delivering agents to a vaginal tract |
CA2601773A1 (en) * | 2005-02-03 | 2006-08-10 | Duramed Pharmaceuticals, Inc. | Compositions of unconjugated estrogens and methods for their use |
DK1933810T3 (da) | 2005-08-11 | 2013-01-28 | Childrens Medical Center | Intravesikal lægemiddelafgivelsesindretning og fremgangsmåde |
US20070077269A1 (en) * | 2005-10-04 | 2007-04-05 | Woodward John R | Method of birth control and hormone regulation |
CA2625264C (en) | 2005-10-13 | 2015-12-15 | Synthes (U.S.A.) | Drug-impregnated sleeve for a medical implant |
GB0613333D0 (en) * | 2006-07-05 | 2006-08-16 | Controlled Therapeutics Sct | Hydrophilic polyurethane compositions |
GB0613638D0 (en) * | 2006-07-08 | 2006-08-16 | Controlled Therapeutics Sct | Polyurethane elastomers |
US20080160065A1 (en) * | 2006-07-12 | 2008-07-03 | Janet Anne Halliday | Drug delivery polymer with hydrochloride salt of clindamycin |
GB0620685D0 (en) * | 2006-10-18 | 2006-11-29 | Controlled Therapeutics Sct | Bioresorbable polymers |
CA2698143C (en) * | 2007-06-26 | 2016-01-19 | Warner Chilcott Company, Llc | Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs |
NZ585449A (en) | 2007-12-11 | 2012-07-27 | Massachusetts Inst Technology | Implantable drug delivery device and methods for treatment of the bladder and other body vestcles or lumens |
JP5908279B2 (ja) * | 2008-08-09 | 2016-04-26 | マサチューセッツ インスチテュート オブ テクノロジーMassachusetts Institute Of Technology | 移植可能な薬物送達デバイス並びに男性の尿生殖器及び周囲組織を治療する方法 |
EP2437684B1 (en) | 2009-06-03 | 2022-06-15 | ForSight Vision5, Inc. | Anterior segment drug delivery |
SG177360A1 (en) | 2009-06-26 | 2012-02-28 | Taris Biomedical Inc | Implantable drug delivery devices and methods of making the same |
US9017312B2 (en) | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
US8580294B2 (en) | 2010-10-19 | 2013-11-12 | International Partnership For Microbicides | Platinum-catalyzed intravaginal rings |
CA2823783C (en) | 2011-01-10 | 2023-03-21 | Taris Biomedical, Inc. | Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding |
CN103379902B (zh) | 2011-02-04 | 2015-11-25 | 塔里斯生物医药公司 | 用于低溶解度药物的控制释放的可植入装置 |
KR102071083B1 (ko) | 2011-09-14 | 2020-01-29 | 포사이트 비젼5, 인크. | 안내 삽입물 장치 및 방법 |
TWI590843B (zh) | 2011-12-28 | 2017-07-11 | 信迪思有限公司 | 膜及其製造方法 |
RU2652063C2 (ru) | 2012-10-26 | 2018-04-24 | Форсайт Вижн5, Инк. | Офтальмологическая система для замедленного высвобождения лекарственного средства в глазу |
BR112015022433B1 (pt) | 2013-03-15 | 2022-06-21 | Taris Biomedical Llc | Dispositivo de liberação de droga intravesical |
US20160144067A1 (en) | 2013-06-21 | 2016-05-26 | DePuy Synthes Products, Inc. | Films and methods of manufacture |
IL299897B2 (en) | 2013-08-19 | 2024-02-01 | Taris Biomedical Llc | Devices and methods for administering multiple units of drug |
CN104546668B (zh) * | 2013-10-23 | 2019-03-05 | 国家卫生计生委科学技术研究所 | 液体硅橡胶为载体的药物缓控释系统的制备及应用 |
US10137031B2 (en) | 2013-11-14 | 2018-11-27 | International Partnership For Microbicides, Inc. | Combination therapy intravaginal rings |
CA2944436C (en) * | 2014-04-01 | 2023-08-22 | Poly-Med, Inc. | Contraceptive and related device |
EP3283004A4 (en) | 2015-04-13 | 2018-12-05 | Forsight Vision5, Inc. | Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent |
US10894150B2 (en) | 2015-04-23 | 2021-01-19 | Taris Biomedical Llc | Drug delivery devices with drug-permeable component and methods |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3545439A (en) * | 1968-01-04 | 1970-12-08 | Upjohn Co | Medicated devices and methods |
US4291014A (en) * | 1979-01-11 | 1981-09-22 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing estradiol diacetate |
US4438139A (en) * | 1979-08-14 | 1984-03-20 | Key Pharmaceuticals, Inc. | Polymeric diffusion matrix containing estrogens |
SE8602666D0 (sv) * | 1986-06-16 | 1986-06-16 | Leo Ab | Intravaginal devices |
-
1995
- 1995-12-18 IL IL11643395A patent/IL116433A/en not_active IP Right Cessation
- 1995-12-19 AU AU43991/96A patent/AU692659B2/en not_active Ceased
- 1995-12-19 DE DE69508791T patent/DE69508791T2/de not_active Expired - Lifetime
- 1995-12-19 TR TR95/01599A patent/TR199501599A2/xx unknown
- 1995-12-19 EP EP95942772A patent/EP0799025B1/en not_active Expired - Lifetime
- 1995-12-19 DK DK95942772T patent/DK0799025T3/da active
- 1995-12-19 PE PE1995287516A patent/PE62796A1/es not_active Application Discontinuation
- 1995-12-19 WO PCT/IE1995/000063 patent/WO1996019196A1/en active IP Right Grant
- 1995-12-19 US US08/849,329 patent/US5855906A/en not_active Expired - Lifetime
- 1995-12-19 NZ NZ298490A patent/NZ298490A/xx unknown
- 1995-12-19 AT AT95942772T patent/ATE178204T1/de not_active IP Right Cessation
- 1995-12-19 JP JP8519650A patent/JPH10510825A/ja not_active Ceased
- 1995-12-19 CA CA002207622A patent/CA2207622C/en not_active Expired - Lifetime
- 1995-12-19 AR ARP950100619A patent/AR002010A1/es unknown
- 1995-12-19 CN CNB951968947A patent/CN1138526C/zh not_active Expired - Lifetime
- 1995-12-19 ES ES95942772T patent/ES2133841T3/es not_active Expired - Lifetime
-
1997
- 1997-06-17 NO NO19972798A patent/NO316707B1/no unknown
- 1997-06-17 FI FI972579A patent/FI119414B/fi not_active IP Right Cessation
-
1999
- 1999-06-29 GR GR990401699T patent/GR3030614T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
PE62796A1 (es) | 1996-12-28 |
NO972798D0 (no) | 1997-06-17 |
FI972579A (fi) | 1997-06-17 |
CN1138526C (zh) | 2004-02-18 |
AU692659B2 (en) | 1998-06-11 |
EP0799025A1 (en) | 1997-10-08 |
AU4399196A (en) | 1996-07-10 |
DE69508791T2 (de) | 1999-12-02 |
CA2207622A1 (en) | 1996-06-27 |
AR002010A1 (es) | 1998-01-07 |
ATE178204T1 (de) | 1999-04-15 |
JPH10510825A (ja) | 1998-10-20 |
DE69508791D1 (de) | 1999-05-06 |
TR199501599A2 (tr) | 1996-07-21 |
IL116433A0 (en) | 1996-03-31 |
DK0799025T3 (da) | 1999-10-18 |
FI119414B (fi) | 2008-11-14 |
GR3030614T3 (en) | 1999-10-29 |
NZ298490A (en) | 1999-11-29 |
FI972579A0 (fi) | 1997-06-17 |
NO316707B1 (no) | 2004-04-13 |
CN1170353A (zh) | 1998-01-14 |
EP0799025B1 (en) | 1999-03-31 |
CA2207622C (en) | 2006-10-17 |
WO1996019196A1 (en) | 1996-06-27 |
US5855906A (en) | 1999-01-05 |
NO972798L (no) | 1997-08-19 |
ES2133841T3 (es) | 1999-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5855906A (en) | Intravaginal drug delivery devices for the administration of 17β-oestradiol precursors | |
US6416780B1 (en) | Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors | |
Brannon-Peppas | Novel vaginal drug release applications | |
US5543150A (en) | Method of progesterone delivery and affect thereof | |
US20080199511A1 (en) | Sustained Release Compositions Containing Progesterone Receptor Modulators | |
US20080085877A1 (en) | Therapeutic methods of using estrogen compositions | |
US20050197651A1 (en) | Vaginal ring preparation and its application | |
Nash | Controlled release systems for contraception | |
SK54694A3 (en) | Subcutaneous implantants derivatives nomegestrol based | |
JPS62298532A (ja) | 膣挿入デバイス | |
US6642219B1 (en) | Progestogen-antiprogestogen regimens | |
IES950959A2 (en) | Intravaginal drug delivery devices for the administration of 17ß-oestradiol precursors | |
US20230404911A1 (en) | Drug delivery system for ultra-low dose estrogen combinations and methods and uses thereof | |
Malcolm | Vaginal rings for controlled-release drug delivery | |
AU689133C (en) | Novel method of progesterone delivery and affect thereof | |
Watkinson | The pharmacokinetics of drug delivery systems in hormone replacement therapy | |
Davey | Hormone replacement therapy | |
ZA200106689B (en) | Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding. | |
WO2008018872A1 (en) | Therapeutic methods of using estrogen compositions | |
WO2010015372A1 (de) | Schwangerschaftsvermeidung durch gestagene | |
MXPA00004610A (en) | Progestogen-antiprogestogen regimens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |